Information Provided By:
Fly News Breaks for December 22, 2015
SRNE
Dec 22, 2015 | 07:49 EDT
FBR Capital analyst Ed White started Sorrento Therapeutics with an Outperform rating and $22 price target.
News For SRNE From the Last 2 Days
There are no results for your query SRNE